Literature DB >> 6280874

Partially deficient methylation of cytosine in DNA at CCATGG sites stimulates genetic recombination of bacteriophage lambda.

B E Korba, J B Hays.   

Abstract

Lambda bacteriophages grown on arl mutants of Escherichia coli ("Arl-" phages) display intermediate levels of cytosine methylation: less 5-methylcytosine (m5C) than phages grown on wild-type bacteria ("Arl+" phages) but more than phages grown on dcm mutants, and thus lacking the methylated sequences (Cm5CATGG) characteristic of E. coli K-12 bacteria ("Dcm-" phages). "Arl-" phages are one twelfth as resistant to Eco RII restriction (recognition site CCATGG) as "Arl+" phages, but 40-fold more resistant than "Dcm-" phages. Chromatographic analyses show the 5-methylcytosine content of "Arl-" DNA to be one third that of "Arl+" DNA. Altered cytosine methylation frequency correlates with two previously described properties of "Arl-" phages, increased genetic recombination and unusual sensitivity of phage DNA to endonuclease S1, which are absent in phages grown on dcm or dcm arl bacteria. Methylated/unmethylated heteroduplex DNA prepared in vitro (one strand from Eco RII-modified phages/one from "Dcm-" phages) is highly recombinogenic but not S1-sensitive. We hypothesize that hemimethylated CCATGG sites in "Arl-" DNA are necessary and sufficient for enhanced recombination, and necessary but not sufficient for S1 sensitivity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6280874     DOI: 10.1016/0092-8674(82)90208-2

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  11 in total

1.  Presence of 5-methylcytosine in CC(A/T)GG sequences (Dcm methylation) in DNAs from different bacteria.

Authors:  M C Gomez-Eichelmann; A Levy-Mustri; J Ramirez-Santos
Journal:  J Bacteriol       Date:  1991-12       Impact factor: 3.490

2.  Induction of a step in carcinogenesis that is normally associated with mutagenesis by nonmutagenic concentrations of 5-azacytidine.

Authors:  N Bouck; D Kokkinakis; J Ostrowsky
Journal:  Mol Cell Biol       Date:  1984-07       Impact factor: 4.272

3.  Specific mismatch correction in bacteriophage lambda crosses by very short patch repair.

Authors:  M Lieb
Journal:  Mol Gen Genet       Date:  1983

4.  Conservation of Dcm-mediated cytosine DNA methylation in Escherichia coli.

Authors:  Kevin T Militello; Robert D Simon; Mehr Qureshi; Robert Maines; Michelle L VanHorne; Stacy M Hennick; Sangeeta K Jayakar; Sarah Pounder
Journal:  FEMS Microbiol Lett       Date:  2012-01-06       Impact factor: 2.742

Review 5.  Deciphering bacterial epigenomes using modern sequencing technologies.

Authors:  John Beaulaurier; Eric E Schadt; Gang Fang
Journal:  Nat Rev Genet       Date:  2019-03       Impact factor: 53.242

6.  Genomics of DNA cytosine methylation in Escherichia coli reveals its role in stationary phase transcription.

Authors:  Christina Kahramanoglou; Ana I Prieto; Supriya Khedkar; Bettina Haase; Ankur Gupta; Vladimir Benes; Gillian M Fraser; Nicholas M Luscombe; Aswin S N Seshasayee
Journal:  Nat Commun       Date:  2012-06-06       Impact factor: 14.919

7.  Comparative sequence analysis of a multidrug-resistant plasmid from Aeromonas hydrophila.

Authors:  Carmelo S Del Castillo; Jun-Ichi Hikima; Ho-Bin Jang; Seong-Won Nho; Tae-Sung Jung; Janenuj Wongtavatchai; Hidehiro Kondo; Ikuo Hirono; Haruko Takeyama; Takashi Aoki
Journal:  Antimicrob Agents Chemother       Date:  2012-10-15       Impact factor: 5.191

8.  Methylated cytosine at Dcm (CCATGG) sites in Escherichia coli: possible function and evolutionary implications.

Authors:  M C Gómez-Eichelmann; J Ramírez-Santos
Journal:  J Mol Evol       Date:  1993-07       Impact factor: 2.395

Review 9.  Eukaryotic DNA methylation.

Authors:  D N Cooper
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

10.  DNA cytosine methylation at the lexA promoter of Escherichia coli is stationary phase specific.

Authors:  Elizabeth B Lewis; Edwin Chen; Matthew J Culyba
Journal:  G3 (Bethesda)       Date:  2022-02-04       Impact factor: 3.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.